Autres langues MedRx Co., Ltd

Actions

4586

JP3921220004

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
113 ^JPY	-2,59%		-2,59%	-25,17%

2023	MedRx Co. déclare ses résultats pour le premier trimestre clos le 31 mars 2023	CI
2019	MedRx Co. Ltd. annonce les résultats des bénéfices consolidés pour les neuf mois terminés le 30 septembre 2019 ; fournit des prévisions de bénéfices consolidés pour l'année se terminant le 31 décembre 2019.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

MedRx : Notice of revised forecasts of consolidated financial results	24/04
MEDRx : Collaboration Partner, Alto Neuroscience, Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia	24/04
MedRx Co., Ltd announced that it has received ¥1.9076 million in funding from Evolution Capital Management LLC	05/02
MedRx Co., Ltd announced that it expects to receive ¥1.9076 million in funding from Evolution Capital Management LLC	11/01
MedRx : Fair Research Inc. Report ( October 12, 2023)	26/10/23
MedRx : Prospect of NDA Re-Submission for MRX-5LBT	10/10/23
MedRx : and Alto Neuroscience Enter Development Agreement for Novel CNS Targeted Medication	25/09/23
MedRx : H1 FY2023 Business Highlight & Financial Results	28/08/23
MedRx : Summary of Business Results for the Second Quarter Ended June 30, 2023 (Consolidated)	18/08/23
MedRx Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
MedRx : Fair Research Inc. Report ( April 10, 2023)	20/04/23
MedRx Co., Ltd announced that it has received ¥1.2272 million in funding from Evolution Capital Management, LLC	24/03/23
MedRx Co., Ltd announced that it expects to receive ¥1.2272 million in funding from Evolution Capital Management, LLC	08/03/23
MedRx : FY2022Business Highlight & Financial Results	02/03/23
MedRx : Fair Research Inc. Report (September 14, 2022)	28/09/22
MedRx : H1 FY2022 Business Highlight & Financial Results	30/08/22
MedRx Co., Ltd announced that it expects to receive ¥3.904 million in funding	22/08/22
MedRx Co., Ltd announced that it has received ¥552.489 million in funding from Macquarie Bank Limited, Investment Arm	03/06/21
MedRx Co., Ltd announced that it expects to receive funding from Macquarie Bank Limited, Investment Arm	18/05/21
Evolution Capital Withdraws Shareholder Proposal to MedRx	31/12/20

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues MedRx Co., Ltd

Actions

4586

JP3921220004

Autres langues

Filtres